Tobira Therapeutics Lands $15,000,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=141cb4e8-2d7a-44ae-a5be-45c5cb5d6460 - Date
7/1/2014 - Company Name
Tobira Therapeutics - Mailing Address
701 Gateway Blvd. South San Francisco, CA 94080 USA - Company Description
Tobira Therapeutics acquires, develops, and commercializes innovative products for the treatment of important unmet medical needs in infectious diseases such as HIV/AIDS, hepatitis, and other associated infectious conditions. - Website
http://www.tobiratherapeutics.com - Transaction Type
Debt - Transaction Amount
$15,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
The facility will support the development of CVC for the treatment of nonalcoholic steatohepatitis (NASH) and for working capital and general corporate needs. - M&A Terms
- Venture Investor
